Suven Life Sciences

114.10
+0.04
(0.04%)
Market Cap
2,488.22
Eps
-4.82
PE Ratio (TTM)
-
Dividend Yield
0.00
Industry
Healthcare
52 Week High
169.30
52 Week low
82.95
PB Ratio
12.92
Debt to Equity
0.00
Sector
Healthcare Technology
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Company News

View All News
Caret
negative
Suven Life Sciences Reports Increased Q3 Net Loss3 days ago
Suven Life Sciences has reported a significant increase in net loss for the third quarter, rising to 133 million rupees from 47 million rupees in the same period last year. The company's revenue, however, showed substantial growth, reaching 16.1 billion rupees compared to 24.5 million rupees in the previous year's Q3.
negative
Suven Life Sciences Reports Increased Q3 Net Loss5 days ago
Suven Life Sciences reported a net loss of 133 million rupees in Q3, compared to a loss of 47 million rupees in the same period last year. The company's revenue decreased to 16.1 billion rupees from 24.5 million rupees year-over-year.
Growth Rate
Revenue Growth
49.09 %
Net Income Growth
-11.16 %
Cash Flow Change
0.44 %
ROE
23.48 %
ROCE
24.98 %
EBITDA Margin (Avg.)
-39.03 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
529
519
565
649
313
29
21
13
22
33
22
Expenses
361
398
415
427
300
130
94
134
139
140
160
EBITDA
168
121
150
222
13
-102
-72
-121
-117
-107
-138
Operating Profit %
31 %
20 %
24 %
32 %
-5 %
-803 %
-594 %
-1,033 %
-930 %
-1,095 %
-2,189 %
Depreciation
12
18
21
21
11
4
4
4
7
7
6
Interest
5
6
6
5
2
1
1
1
0
0
0
Profit Before Tax
152
98
123
196
0
-106
-78
-122
-118
-106
-144
Tax
43
26
36
72
24
-12
-5
0
0
-1
-1
Net Profit
109
72
87
124
-24
-94
-72
-122
-118
-105
-143
EPS in ₹
9.04
5.61
6.85
9.72
-1.88
-7.40
-5.67
-9.05
-5.42
-4.82
-6.60

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
773
752
816
919
303
182
128
108
389
285
Fixed Assets
172
305
306
308
22
25
21
38
37
28
Current Assets
477
428
492
570
281
66
103
67
252
257
Capital Work in Progress
107
7
10
25
0
0
5
4
0
0
Investments
0
0
301
279
223
0
0
45
46
76
Other Assets
494
439
199
308
58
157
103
22
305
181
Total Liabilities
773
752
816
919
303
182
128
108
389
285
Current Liabilities
127
111
119
122
40
27
16
8
11
14
Non Current Liabilities
86
46
30
30
25
12
5
4
3
1
Total Equity
559
595
667
767
239
143
108
96
375
270
Reserve & Surplus
547
583
654
755
226
131
58
82
354
248
Share Capital
13
13
13
13
13
13
13
15
22
22

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
212
-39
-232
17
-18
14
-5
-4
32
-22
Investing Activities
-110
-39
-311
-1
30
146
56
-22
-248
94
Operating Activities
143
68
109
70
-53
-135
-96
-128
-116
-116
Financing Activities
179
-68
-30
-52
5
3
35
146
396
-1

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Nov 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
60.00 %
60.00 %
60.00 %
60.00 %
64.98 %
64.98 %
64.98 %
64.98 %
69.57 %
69.57 %
69.57 %
69.57 %
69.57 %
69.57 %
70.27 %
70.27 %
70.27 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.50 %
0.54 %
0.46 %
0.45 %
0.34 %
0.34 %
DIIs
0.21 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.13 %
0.12 %
0.11 %
0.11 %
0.08 %
0.01 %
0.12 %
1.17 %
1.17 %
1.05 %
1.06 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
33.92 %
34.22 %
33.19 %
33.24 %
28.69 %
29.02 %
27.37 %
27.43 %
22.98 %
23.00 %
23.29 %
24.38 %
24.05 %
22.29 %
22.66 %
22.15 %
22.31 %
No of Share Holders
77,650
86,008
81,475
80,195
81,062
81,038
80,116
80,536
80,838
78,634
76,291
80,953
74,003
68,959
66,116
63,975
63,537

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 1 1.5 1.5 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield (%) 0.00 12.85 0.57 7.61 0.00 0.00 0.00 0.00 0.00 0.00
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
757.85 30,506.27 64.05 3,579.20 9.66 510 17.58 32.06
612.90 14,664.79 40.08 2,665.90 12.77 337 22.27 47.78
114.00 2,486.04 - 32.80 49.09 -105 6.46 33.83
837.25 1,859.81 31.09 322.30 0.22 41 112.87 44.32
11.51 170.27 - 67.20 -65.97 -120 -6.67 24.30
68.01 160.09 - 769.70 -22.39 -59 -121.48 43.87
45.07 71.35 - 40.30 8.04 -1 150.00 40.05
24.00 34.66 45.45 80.00 -3.26 2 0.00 52.83
34.00 21.50 - 9.80 40.00 -9 -450.00 30.68

Corporate Action

Technical Indicators

RSI(14)
Neutral
33.83
ATR(14)
Less Volatile
8.10
STOCH(9,6)
Oversold
6.84
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
-1.92
ADX(14)
Weak Trend
19.03
UO(9)
Bullish
21.78
ROC(12)
Downtrend And Accelerating
-14.93
WillR(14)
Oversold
-96.01